CompletedNot Applicable

Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy

China96 participantsStarted 2023-12-01

Plain-language summary

The aim of this randomized controlled trial (RCT) is to assess the Quality of Recovery (QoR) in Breast-conserving Surgery (BCS) with Sentinel Lymph Node Biopsy (SLNB) using Pectoral Nerves (PECS) Block and General Anesthesia (GA). The primary objectives are as follows: First, to determine if the PECS group exhibits better QoR; Second, to investigate if the PECS group experiences less postoperative pain and complications; Third, to examine if the PECS group demonstrates more stable hemodynamics.

Who can participate

Age range18 Years – 70 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients scheduled for breast-conserving surgery with sentinel lymph node biopsy. * Age between 18 and 70 years. * Body Mass Index (BMI) \< 30 kg/m2. * American Society of Anesthesiologists (ASA) classification grade I-III. Exclusion Criteria: * Contraindications to regional anesthesia: site infection at the puncture site, allergy to local anesthetics, coagulation disorders, or bleeding risks. * Impaired liver or kidney function. * Pregnancy, lactation, possibility of pregnancy, or planned pregnancy. * Preoperative use of analgesic drugs, history of chronic pain, or history of opioid abuse. * Mental illness. * Patients who refuse to participate. * Patients deemed unsuitable for the clinical trial by the researchers.

What they're measuring

Postoperative QoR-15 at 6 hours

Timeframe: 6 hours after the surgery

Trial details

NCT IDNCT06120439

SponsorJun Zhang

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-05-11

View on ClinicalTrials.gov More Breast Cancer trials